All In Biotech

Free tool

FAERS Monitor: Provera

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 011839 or its brand name (Provera, Medroxyprogesterone Acetate). Reports on generic versions are filed under their own applications.

Reports

28,420

Serious

26,121

92% of reports

Hospitalization

3,170

Death reported

818

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • breast cancer female9,758
  • breast cancer8,138
  • breast cancer metastatic1,380
  • meningioma854
  • oestrogen receptor assay positive773
  • progesterone receptor assay positive673
  • pain521
  • drug ineffective520
  • breast cancer in situ516
  • ovarian cancer499
  • nausea470
  • fatigue448
  • headache391
  • anxiety390
  • cerebrovascular accident389

Reports by year received

View as table
YearReports
20043,215
20052,334
20061,804
2007811
20081,983
20093,953
20106,981
20111,312
2012567
2013249
2014234
2015296
2016316
2017264
2018299
2019368
2020407
2021320
2022301
2023315
2024445
2025883
2026762

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,025,739 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
progesterone receptor assay positiveSignal6731907.71654.4357,872
oestrogen receptor assay positiveSignal7731584.21398.9388,853
breast cancer in situSignal516505.0451.8153,957
breast cancer femaleSignal9,758425.1415.92,625,218
breast cancer metastaticSignal1,380109.0103.2128,712
breast cancerSignal8,13870.769.3512,632
meningiomaSignal85442.839.932,908
ovarian cancerSignal49942.338.718,995
cerebrovascular accident3891.71.5112
anxiety3901.00.90
pain5210.60.6118
headache3910.50.4253
nausea4700.40.4349
fatigue4480.40.4360
drug ineffective5200.30.3953

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.